Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron for PDNV in Gynecologic Surgery
NCT03409835Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Mar 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ramosetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoints: The change in the occurrence of postoperative nausea at 48 hour and The change in the occurrence of postoperative vomiting at 48 hour. Status: unknown.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03409835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03409835.